ahlam1399
09-21-2016, 05:40 AM
Senate Republicans seek probe of Mylan EpiPen oversight
NEW YORK (Reuters) - Mylan NV faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company’s rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=xJM8re8-pWM:aJp1WM9_DzM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xJM8re8-pWM:aJp1WM9_DzM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=xJM8re8-pWM:aJp1WM9_DzM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xJM8re8-pWM:aJp1WM9_DzM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=xJM8re8-pWM:aJp1WM9_DzM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/xJM8re8-pWM
NEW YORK (Reuters) - Mylan NV faced new scrutiny over price hikes for its anti-allergy EpiPen on Tuesday, with U.S. lawmakers calling for a probe of oversight of the company’s rebates to government healthcare plans, while West Virginia said it was investigating whether Mylan defrauded its Medicaid department.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=xJM8re8-pWM:aJp1WM9_DzM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xJM8re8-pWM:aJp1WM9_DzM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=xJM8re8-pWM:aJp1WM9_DzM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=xJM8re8-pWM:aJp1WM9_DzM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=xJM8re8-pWM:aJp1WM9_DzM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/xJM8re8-pWM